Mild Hypertension [electronic resource] : Current controversies and new approaches /

There is clear evidence that in severe hypertension lowering blood pressure, by drug therapy decreases the incidence of major cardiovascular events. Recent studies suggest that such benefit may also extend to patients with mild to moderate hypertension. The putative benefits of drugs may be offset, however, by their adverse effects and a prime example is the increased incidence of impotence and metabolic disorders in patients on thiazide diuretics. There is, therefore, a real need to look further into the therapy of patients with mild to moderate hypertension. The ideal drug in such patients would oppose the basic mechanisms responsible for the elevation in blood pressure, would prevent counter-regulatory responses and would have minimal side-effects in both the short-term and the long-term, the latter being of particular importance to younger patients. These aspects were considered at the symposium "Mild hypertension. Current con­ troversies and new approaches" held at Titisee in West Germany, October 13-15 in 1983. The foundation for discussion was set with an exposition of the neural and hormonal regulation of blood pressure in normal man followed by a consideration of the pos~ible pathophysiological mechanisms involved in patients with hypertension. Particular at­ tention was focused on the central nervous system and on effects governed by activity of the peripheral nervous system as these may well provide further opportunities for logical therapeutic intervention in clinical hypertension. The current management of mild to moderate hypertension was then reviewed.

Saved in:
Bibliographic Details
Main Authors: Weber, M. A. editor., Mathias, C. J. editor., SpringerLink (Online service)
Format: Texto biblioteca
Language:eng
Published: Heidelberg : Steinkopff, 1984
Subjects:Medicine., Cardiology., Medicine & Public Health.,
Online Access:http://dx.doi.org/10.1007/978-3-642-85334-0
Tags: Add Tag
No Tags, Be the first to tag this record!
id KOHA-OAI-TEST:216176
record_format koha
institution COLPOS
collection Koha
country México
countrycode MX
component Bibliográfico
access En linea
En linea
databasecode cat-colpos
tag biblioteca
region America del Norte
libraryname Departamento de documentación y biblioteca de COLPOS
language eng
topic Medicine.
Cardiology.
Medicine & Public Health.
Cardiology.
Medicine.
Cardiology.
Medicine & Public Health.
Cardiology.
spellingShingle Medicine.
Cardiology.
Medicine & Public Health.
Cardiology.
Medicine.
Cardiology.
Medicine & Public Health.
Cardiology.
Weber, M. A. editor.
Mathias, C. J. editor.
SpringerLink (Online service)
Mild Hypertension [electronic resource] : Current controversies and new approaches /
description There is clear evidence that in severe hypertension lowering blood pressure, by drug therapy decreases the incidence of major cardiovascular events. Recent studies suggest that such benefit may also extend to patients with mild to moderate hypertension. The putative benefits of drugs may be offset, however, by their adverse effects and a prime example is the increased incidence of impotence and metabolic disorders in patients on thiazide diuretics. There is, therefore, a real need to look further into the therapy of patients with mild to moderate hypertension. The ideal drug in such patients would oppose the basic mechanisms responsible for the elevation in blood pressure, would prevent counter-regulatory responses and would have minimal side-effects in both the short-term and the long-term, the latter being of particular importance to younger patients. These aspects were considered at the symposium "Mild hypertension. Current con­ troversies and new approaches" held at Titisee in West Germany, October 13-15 in 1983. The foundation for discussion was set with an exposition of the neural and hormonal regulation of blood pressure in normal man followed by a consideration of the pos~ible pathophysiological mechanisms involved in patients with hypertension. Particular at­ tention was focused on the central nervous system and on effects governed by activity of the peripheral nervous system as these may well provide further opportunities for logical therapeutic intervention in clinical hypertension. The current management of mild to moderate hypertension was then reviewed.
format Texto
topic_facet Medicine.
Cardiology.
Medicine & Public Health.
Cardiology.
author Weber, M. A. editor.
Mathias, C. J. editor.
SpringerLink (Online service)
author_facet Weber, M. A. editor.
Mathias, C. J. editor.
SpringerLink (Online service)
author_sort Weber, M. A. editor.
title Mild Hypertension [electronic resource] : Current controversies and new approaches /
title_short Mild Hypertension [electronic resource] : Current controversies and new approaches /
title_full Mild Hypertension [electronic resource] : Current controversies and new approaches /
title_fullStr Mild Hypertension [electronic resource] : Current controversies and new approaches /
title_full_unstemmed Mild Hypertension [electronic resource] : Current controversies and new approaches /
title_sort mild hypertension [electronic resource] : current controversies and new approaches /
publisher Heidelberg : Steinkopff,
publishDate 1984
url http://dx.doi.org/10.1007/978-3-642-85334-0
work_keys_str_mv AT webermaeditor mildhypertensionelectronicresourcecurrentcontroversiesandnewapproaches
AT mathiascjeditor mildhypertensionelectronicresourcecurrentcontroversiesandnewapproaches
AT springerlinkonlineservice mildhypertensionelectronicresourcecurrentcontroversiesandnewapproaches
_version_ 1756269579874598912
spelling KOHA-OAI-TEST:2161762018-07-30T23:51:36ZMild Hypertension [electronic resource] : Current controversies and new approaches / Weber, M. A. editor. Mathias, C. J. editor. SpringerLink (Online service) textHeidelberg : Steinkopff,1984.engThere is clear evidence that in severe hypertension lowering blood pressure, by drug therapy decreases the incidence of major cardiovascular events. Recent studies suggest that such benefit may also extend to patients with mild to moderate hypertension. The putative benefits of drugs may be offset, however, by their adverse effects and a prime example is the increased incidence of impotence and metabolic disorders in patients on thiazide diuretics. There is, therefore, a real need to look further into the therapy of patients with mild to moderate hypertension. The ideal drug in such patients would oppose the basic mechanisms responsible for the elevation in blood pressure, would prevent counter-regulatory responses and would have minimal side-effects in both the short-term and the long-term, the latter being of particular importance to younger patients. These aspects were considered at the symposium "Mild hypertension. Current con­ troversies and new approaches" held at Titisee in West Germany, October 13-15 in 1983. The foundation for discussion was set with an exposition of the neural and hormonal regulation of blood pressure in normal man followed by a consideration of the pos~ible pathophysiological mechanisms involved in patients with hypertension. Particular at­ tention was focused on the central nervous system and on effects governed by activity of the peripheral nervous system as these may well provide further opportunities for logical therapeutic intervention in clinical hypertension. The current management of mild to moderate hypertension was then reviewed.Introduction: Some neurological aspects of blood pressure control -- Central and peripheral control of blood pressure -- Central nervous system control of blood pressure -- Blood pressure control and the peripheral sympathetic nervous system -- Baroreflex function and centrally acting antihypertensive drugs -- Haemodynamic effects of antihypertensive agents in man -- Vascular autonomy and its relation to the action of antihypertensive drugs -- General discussion -- Therapeutic consequences -- Therapeutic decisions in mild hypertension: an introductory overview -- When to treat? Recent trials in mild hypertension. Epidemiological data and conclusions -- Current assessment of the stepped-care treatment of mild hypertension: diuretics, beta-blockers, vasodilators versus clonidine -- Use of centrally-acting agonists in the treatment of mild hypertension in the elderly patient -- Sympathetic nervous system activity in the obese hypertensive patient: potential role for central alpha-adrenoreceptor agonists -- Clonidine for treating patients with mild hypertension and angina pectoris -- New pharmacological approaches in the treatment of mild hypertension. The potential role of converting enzyme inhibitors and calcium blocking agents -- General discussion -- Advances in treatment -- Rate-controlled drug delivery and the reduction of risk -- Clonidine rate — controlled system: technology and kinetics -- Absorption of clonidine from a transdermal therapeutic system when applied to different body sites -- Clinical experience with clonidine TTS -- Clinical effectiveness of the transdermal route of antihypertensive treatment -- Roundtable discussion on the use of transdermal medication: clinical characteristics and skin reactions -- Panel discussion: the role of clonidine in the treatment of mild hypertension -- Concluding remarks -- Participants.There is clear evidence that in severe hypertension lowering blood pressure, by drug therapy decreases the incidence of major cardiovascular events. Recent studies suggest that such benefit may also extend to patients with mild to moderate hypertension. The putative benefits of drugs may be offset, however, by their adverse effects and a prime example is the increased incidence of impotence and metabolic disorders in patients on thiazide diuretics. There is, therefore, a real need to look further into the therapy of patients with mild to moderate hypertension. The ideal drug in such patients would oppose the basic mechanisms responsible for the elevation in blood pressure, would prevent counter-regulatory responses and would have minimal side-effects in both the short-term and the long-term, the latter being of particular importance to younger patients. These aspects were considered at the symposium "Mild hypertension. Current con­ troversies and new approaches" held at Titisee in West Germany, October 13-15 in 1983. The foundation for discussion was set with an exposition of the neural and hormonal regulation of blood pressure in normal man followed by a consideration of the pos~ible pathophysiological mechanisms involved in patients with hypertension. Particular at­ tention was focused on the central nervous system and on effects governed by activity of the peripheral nervous system as these may well provide further opportunities for logical therapeutic intervention in clinical hypertension. The current management of mild to moderate hypertension was then reviewed.Medicine.Cardiology.Medicine & Public Health.Cardiology.Springer eBookshttp://dx.doi.org/10.1007/978-3-642-85334-0URN:ISBN:9783642853340